Icon Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $438K | Sell |
13,201
-5,997
| -31% | -$199K | 0.05% | 185 |
|
|
2023
Q2 | $704K | Buy |
19,198
+219
| +1% | +$8.03K | 0.07% | 161 |
|
|
2023
Q1 | $774K | Buy |
+18,979
| New | +$774K | 0.08% | 161 |
|
|
2022
Q2 | $873K | Sell |
16,651
-3,082
| -16% | -$162K | 0.1% | 148 |
|
|
2022
Q1 | $1.02M | Buy |
19,733
+4,320
| +28% | +$224K | 0.1% | 147 |
|
|
2021
Q4 | $910K | Sell |
15,413
-5,308
| -26% | -$313K | 0.09% | 157 |
|
|
2021
Q3 | $891K | Sell |
20,721
-6,482
| -24% | -$279K | 0.09% | 166 |
|
|
2021
Q2 | $1.07M | Buy |
27,203
+2,773
| +11% | +$109K | 0.11% | 150 |
|
|
2021
Q1 | $885K | Buy |
24,430
+11,560
| +90% | +$419K | 0.11% | 149 |
|
|
2020
Q4 | $474K | Sell |
12,870
-794
| -6% | -$29.2K | 0.07% | 181 |
|
|
2020
Q3 | $476K | Sell |
13,664
-18,092
| -57% | -$630K | 0.09% | 149 |
|
|
2020
Q2 | $985K | Buy |
31,756
+16,335
| +106% | +$507K | 0.24% | 82 |
|
|
2020
Q1 | $478K | Buy |
15,421
+2,124
| +16% | +$65.8K | 0.19% | 63 |
|
|
2019
Q4 | $494K | Buy |
13,297
+1,521
| +13% | +$56.5K | 0.16% | 71 |
|
|
2019
Q3 | $401K | Buy |
11,776
+257
| +2% | +$8.75K | 0.14% | 80 |
|
|
2019
Q2 | $473K | Buy |
11,519
+678
| +6% | +$27.8K | 0.17% | 72 |
|
|
2019
Q1 | $437K | Sell |
10,841
-748
| -6% | -$30.2K | 0.16% | 76 |
|
|
2018
Q4 | $480K | Sell |
11,589
-4,342
| -27% | -$180K | 0.23% | 67 |
|
|
2018
Q3 | $666K | Buy |
15,931
+2,307
| +17% | +$96.4K | 0.28% | 58 |
|
|
2018
Q2 | $469K | Sell |
13,624
-2,211
| -14% | -$76.1K | 0.2% | 82 |
|
|
2018
Q1 | $533K | Sell |
15,835
-4,537
| -22% | -$153K | 0.29% | 78 |
|
|
2017
Q4 | $700K | Buy |
+20,372
| New | +$700K | 0.35% | 65 |
|